CoChat

SARS‐CoV‐2 targets neurons of 3D human brain organoids

Open access

Published version of a preprint

The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

COVID-19 pandemic caused by SARS-CoV-2 infection is a public health emergency. COVID-19 typically exhibits respiratory illness. Unexpectedly, emerging clinical reports indicate that neurological symptoms continue to rise, suggesting detrimental effects of SARS-CoV-2 on the central nervous system (CNS). Here, we show that a Düsseldorf isolate of SARS-CoV-2 enters 3D human brain organoids within 2 days of exposure. We identified that SARS-CoV-2 preferably targets neurons of brain organoids. Imaging neurons of organoids reveal that SARS-CoV-2 exposure is associated with altered distribution of Tau from axons to soma, hyperphosphorylation, and apparent neuronal death. Our studies, therefore, provide initial insights into the potential neurotoxic effect of SARS-CoV-2 and emphasize that brain organoids could model CNS pathologies of COVID-19.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embj.2020106230

Cites

62 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 SARS‐CoV‐2 targets the cortical region of human brain organoids AA positive control experiment. SARS‐CoV-2 readily targets ciliated human respiratory epithelial cells (hRECs). Acetylated α‐tubulin labels cilia. Arrows point SARS‐CoV-2‐positive cells labeled by AB4 (green). Figures display scale bars. Bar diagram at right quantifies frequencies of SARS‐CoV-2‐positive cells in hRECs. At least six hREC sections from three (n = 3) independent samples were examined. Data presented as mean ± SEM.BMock organoids of two age groups Day‐15 (i) and‐60 (ii) display typical cytoarchitecture of brain organoids. L, lumen, VZ, ventricular Zone is containing compact and palisade‐like elongated nuclei of neural progenitor cells (NPCs, blue) and CP, a cortical plate containing TUJ‐1-positive neurons (magenta). Note a distinct difference TUJ‐1 labeling pattern between younger (Day‐15) and older (Day‐60) brain organoid. Figures display scale bars. Representative images from eight organoids cultured in at least three independent batches (n = 3) derived from donor‐1 (IMR90) iPSC line.CCompared to mock organoids (i), SARS‐CoV-2‐exposed Day‐15 organoids display SARS‐CoV-2‐positive cells (AB4, green) in their outer periphery, a region of the cortical plate (ii) that is specified by TUJ-1‐positive neurons (magenta). L, the lumen of a VZ, the inner area of an organoid where NPCs are located, is free from SARS‐CoV-2‐positive cells. Magnified region (dotted while box) is given below. At least 10 organoids from five different batches (n = 5) are tested. Figures display scale bars.DSARS-CoV‐2-exposed Day‐60 organoids. Compared to Day 15 organoids and mock (i), Day‐60 organoids display an increased number of SARS‐CoV-2‐positive cells (AB4, green) in their cortical plate that is specified by TUJ-1‐positive neurons (magenta) (ii). Magnified region (dotted while box) is given below, showing the perinuclear location of SARS‐CoV-2 in cortical neurons. At least 10 organoids from five different batches (n = 5) are tested. Figures display scale bars.EThe bar diagram quantifies frequencies of SARS‐CoV-2‐positive cells in different brain organoid sections derived from two donor iPSC lines (IMR90 and Crx‐iPS, see Materials and Methods). Please note that each point represents one organoid section. SARS‐CoV-2 shows an enhanced tropism for Day‐60 organoids. Note, comparative statistics are shown between different age groups and respective days post‐infection (dpi) of organoids, and the significance is given as Asterisks in Day‐60 groups. There is no significant difference in SARS‐CoV-2‐positive cells between 2‐ and 4‐dpi within each age groups. At least twelve organoids sections from four (n = 4) independent batches, from each donor and day post‐infections (dpi), were analyzed. One‐way ANOVA, followed by Tukey's multiple comparisons test, ***P < 0.001. Data presented as mean ± SEM.FSubcellular localization SARS‐CoV-2 in cortical neurons. High‐resolution imaging and deconvolution show perinuclear localization of SARS‐CoV-2. SARS‐CoV-2 (AB4, green) and nucleus (gray). Figures display scale bars. Representative images from at least 200 cells are examined. White line surrounds perinuclear border, and red line encircles the nucleus.GDetermination of viral progeny. Supernatants of SARS‐CoV-2 exposed Vero cells, and brain organoids were analyzed for viral RNA assessed by qRT–PCR. While an increase in viral RNA was detected in the supernatants of Vero cells, no apparent increase was identified in brain organoid supernatants. Data are obtained from five technical replicates from four (n = 4) independent batches of organoids. Data presented as mean ± SEM.
Figure 1 SARS‐CoV‐2 targets the cortical region of human brain organoids AA positive control experiment. SARS‐CoV-2 readily targets ciliated human respiratory epithelial cells (hRECs). Acetylated α‐tubulin labels cilia. Arrows point SARS‐CoV-2‐positive cells labeled by AB4 (green). Figures display scale bars. Bar diagram at right quantifies frequencies of SARS‐CoV-2‐positive cells in hRECs. At least six hREC sections from three (n = 3) independent samples were examined. Data presented as mean ± SEM.BMock organoids of two age groups Day‐15 (i) and‐60 (ii) display typical cytoarchitecture of brain organoids. L, lumen, VZ, ventricular Zone is containing compact and palisade‐like elongated nuclei of neural progenitor cells (NPCs, blue) and CP, a cortical plate containing TUJ‐1-positive neurons (magenta). Note a distinct difference TUJ‐1 labeling pattern between younger (Day‐15) and older (Day‐60) brain organoid. Figures display scale bars. Representative images from eight organoids cultured in at least three independent batches (n = 3) derived from donor‐1 (IMR90) iPSC line.CCompared to mock organoids (i), SARS‐CoV-2‐exposed Day‐15 organoids display SARS‐CoV-2‐positive cells (AB4, green) in their outer periphery, a region of the cortical plate (ii) that is specified by TUJ-1‐positive neurons (magenta). L, the lumen of a VZ, the inner area of an organoid where NPCs are located, is free from SARS‐CoV-2‐positive cells. Magnified region (dotted while box) is given below. At least 10 organoids from five different batches (n = 5) are tested. Figures display scale bars.DSARS-CoV‐2-exposed Day‐60 organoids. Compared to Day 15 organoids and mock (i), Day‐60 organoids display an increased number of SARS‐CoV-2‐positive cells (AB4, green) in their cortical plate that is specified by TUJ-1‐positive neurons (magenta) (ii). Magnified region (dotted while box) is given below, showing the perinuclear location of SARS‐CoV-2 in cortical neurons. At least 10 organoids from five different batches (n = 5) are tested. Figures display scale bars.EThe bar diagram quantifies frequencies of SARS‐CoV-2‐positive cells in different brain organoid sections derived from two donor iPSC lines (IMR90 and Crx‐iPS, see Materials and Methods). Please note that each point represents one organoid section. SARS‐CoV-2 shows an enhanced tropism for Day‐60 organoids. Note, comparative statistics are shown between different age groups and respective days post‐infection (dpi) of organoids, and the significance is given as Asterisks in Day‐60 groups. There is no significant difference in SARS‐CoV-2‐positive cells between 2‐ and 4‐dpi within each age groups. At least twelve organoids sections from four (n = 4) independent batches, from each donor and day post‐infections (dpi), were analyzed. One‐way ANOVA, followed by Tukey's multiple comparisons test, ***P < 0.001. Data presented as mean ± SEM.FSubcellular localization SARS‐CoV-2 in cortical neurons. High‐resolution imaging and deconvolution show perinuclear localization of SARS‐CoV-2. SARS‐CoV-2 (AB4, green) and nucleus (gray). Figures display scale bars. Representative images from at least 200 cells are examined. White line surrounds perinuclear border, and red line encircles the nucleus.GDetermination of viral progeny. Supernatants of SARS‐CoV-2 exposed Vero cells, and brain organoids were analyzed for viral RNA assessed by qRT–PCR. While an increase in viral RNA was detected in the supernatants of Vero cells, no apparent increase was identified in brain organoid supernatants. Data are obtained from five technical replicates from four (n = 4) independent batches of organoids. Data presented as mean ± SEM.CC BY-NC-ND · PubMed Central
Figure 2 SARS‐CoV‐2 deregulates of Tau in cortical neurons ATau immunoreactivity (magenta) specifies the cortical plate (CP) surrounding the lumen (L) (i). Selected optic sections at high magnification (ii and iii) and high‐resolution imaging (iv) show Tau localization only in axons of cortical neurons. Note the somas of neurons are free from Tau protein. At least eight organoids from four different batches (n = 4) are tested. Figures display scale bars.BTau localization in SARS‐CoV-2‐positive neurons (AB4, green) in selected optic sections (i). Note, in contrast, to control groups, SARS‐CoV-2‐exposed organoids display mislocalized Tau (magenta) majorly into the somas of neurons (arrowheads). Selected confocal slices are shown to distinguish Tau mislocalization into neuronal soma (arrowheads). At high magnification, neuronal soma is further specified by the perinuclear localization of SARS‐CoV-2 (green) (ii and iii). Bar diagrams at right quantifies the percentage of neurons (Mock and SARS‐CoV-2 exposed) exhibiting mislocalized Tau (iv) and the fraction of SARS‐CoV-2‐positive neurons exhibiting Tau‐positive axons spanning different cortical areas (v). For statistics, at least 300 cells from six organoids from four different batches (n = 4) were tested. Figures display scale bars. Unpaired t‐test with Welch's correction, ***P < 0.001. Data presented as mean ± SD.CSchematic cartoon of differential Tau distribution in mock compared to SARS‐CoV-2‐positive neurons. In mock, Tau is sorted mainly to axons. In SARS‐CoV-2‐positive neurons, Tau is missorted to the soma (determined by Pan‐Tau antibody). Furthermore, phosphorylated Tau (at T231) majorly localizes in the soma (bottom panel, determined by Tau AT‐180 antibody, see below).DIn contrast to controls (i), Tau AT180 antibody (magenta) that specifically recognizes the phosphorylated Threonine 231 of Tau protein distinctly localizes at the somas of SARS‐CoV-2‐positive neurons (AB4, green) (ii). At least four organoids from two different batches (n = 2) are tested. Figures display scale bars.ECo‐localization of SARS‐CoV-2 (AB4, green) and phosphorylated Tau protein (magenta) at somas of cortical neurons revealed by high‐resolution imaging and deconvolution. Representative images from at least 300 cells examined. Figures display scale bars.FThe bar diagram quantifies the fraction of Tau AT180‐positive neurons that co‐localize with SARS‐CoV-2‐positive neurons. For statistics, at least 250 cells from four organoids and two independent batches (n = 2) were examined. Unpaired t‐test with Welch's correction. Data presented as mean ± SEM.
Figure 2 SARS‐CoV‐2 deregulates of Tau in cortical neurons ATau immunoreactivity (magenta) specifies the cortical plate (CP) surrounding the lumen (L) (i). Selected optic sections at high magnification (ii and iii) and high‐resolution imaging (iv) show Tau localization only in axons of cortical neurons. Note the somas of neurons are free from Tau protein. At least eight organoids from four different batches (n = 4) are tested. Figures display scale bars.BTau localization in SARS‐CoV-2‐positive neurons (AB4, green) in selected optic sections (i). Note, in contrast, to control groups, SARS‐CoV-2‐exposed organoids display mislocalized Tau (magenta) majorly into the somas of neurons (arrowheads). Selected confocal slices are shown to distinguish Tau mislocalization into neuronal soma (arrowheads). At high magnification, neuronal soma is further specified by the perinuclear localization of SARS‐CoV-2 (green) (ii and iii). Bar diagrams at right quantifies the percentage of neurons (Mock and SARS‐CoV-2 exposed) exhibiting mislocalized Tau (iv) and the fraction of SARS‐CoV-2‐positive neurons exhibiting Tau‐positive axons spanning different cortical areas (v). For statistics, at least 300 cells from six organoids from four different batches (n = 4) were tested. Figures display scale bars. Unpaired t‐test with Welch's correction, ***P < 0.001. Data presented as mean ± SD.CSchematic cartoon of differential Tau distribution in mock compared to SARS‐CoV-2‐positive neurons. In mock, Tau is sorted mainly to axons. In SARS‐CoV-2‐positive neurons, Tau is missorted to the soma (determined by Pan‐Tau antibody). Furthermore, phosphorylated Tau (at T231) majorly localizes in the soma (bottom panel, determined by Tau AT‐180 antibody, see below).DIn contrast to controls (i), Tau AT180 antibody (magenta) that specifically recognizes the phosphorylated Threonine 231 of Tau protein distinctly localizes at the somas of SARS‐CoV-2‐positive neurons (AB4, green) (ii). At least four organoids from two different batches (n = 2) are tested. Figures display scale bars.ECo‐localization of SARS‐CoV-2 (AB4, green) and phosphorylated Tau protein (magenta) at somas of cortical neurons revealed by high‐resolution imaging and deconvolution. Representative images from at least 300 cells examined. Figures display scale bars.FThe bar diagram quantifies the fraction of Tau AT180‐positive neurons that co‐localize with SARS‐CoV-2‐positive neurons. For statistics, at least 250 cells from four organoids and two independent batches (n = 2) were examined. Unpaired t‐test with Welch's correction. Data presented as mean ± SEM.CC BY-NC-ND · PubMed Central
Figure 3 SARS‐CoV‐2 induces of neuronal death ACells from mock organoids display a healthy nucleus labeled by DAPI (blue) (i). SARS‐CoV-2‐positive cells (green) display condensed (middle panel, ii) and fragmented DNA (bottom panel, iii, arrows). At least 75 cells from two (n = 2) independent batches of organoids were examined. Figures display scale bars.BCompared to mock organoids, (i) SARS‐CoV-2‐exposed organoids (ii) display increased TUNEL‐positive cells (displayed as inverted LUT) at the cortical plate that is specified by TUJ‐1 (magenta). At least four organoids from two (n = 2) independent batches of organoids were examined. Figures display scale bars. The bar diagram below quantifies the frequencies of TUNEL‐positive cells between mock and SARS‐CoV-2‐exposed organoids. Four organoids from two (n = 2) independent batches were examined. Unpaired t‐test, *P < 0.05. Data presented as mean ± SD.CMost of the SARS‐CoV-2‐positive cells (AB4, green) are TUNEL‐positive (i) and some of the SARS‐CoV-2‐positive cells are caspase‐positive (ii). Caspase‐positive cells in SARS‐CoV-2‐exposed organoids display pT231Tau localization at the cell soma specified by AT‐180 (ii), which are not observed in mock organoids (iii). Arrowheads point SARS‐CoV-2‐positive cells (AB4, green) that are also positive for TUNNEL (red), caspase 3 (yellow), and Tau AT‐180 (magenta). Figures display scale bars. Bar diagrams at right quantifies proportions of TUNEL and caspase‐positive cells among SARS‐CoV-2‐positive cells. The second graph below quantifies the proportions of pT231Tau‐positive cells among caspase‐positive cells between control and virus exposed groups. At least 400 cells from four organoids and two independent (n = 2) batches were examined. Unpaired t‐test, **P < 0.01. Data presented as mean ± SEM. TUNEL‐positive cells in control un‐exposed organoids do not contain pT231Tau (iii). Figures display scale bars. Bar diagrams at right quantifies proportions of pT231Tau‐positive cells among TUNNEL‐positive cells between control and virus exposed groups. At least 350 cells from 4 organoids and two independent (n = 2) batches were examined. Unpaired t‐test, ***P < 0.001. Data presented as mean ± SEM.
Figure 3 SARS‐CoV‐2 induces of neuronal death ACells from mock organoids display a healthy nucleus labeled by DAPI (blue) (i). SARS‐CoV-2‐positive cells (green) display condensed (middle panel, ii) and fragmented DNA (bottom panel, iii, arrows). At least 75 cells from two (n = 2) independent batches of organoids were examined. Figures display scale bars.BCompared to mock organoids, (i) SARS‐CoV-2‐exposed organoids (ii) display increased TUNEL‐positive cells (displayed as inverted LUT) at the cortical plate that is specified by TUJ‐1 (magenta). At least four organoids from two (n = 2) independent batches of organoids were examined. Figures display scale bars. The bar diagram below quantifies the frequencies of TUNEL‐positive cells between mock and SARS‐CoV-2‐exposed organoids. Four organoids from two (n = 2) independent batches were examined. Unpaired t‐test, *P < 0.05. Data presented as mean ± SD.CMost of the SARS‐CoV-2‐positive cells (AB4, green) are TUNEL‐positive (i) and some of the SARS‐CoV-2‐positive cells are caspase‐positive (ii). Caspase‐positive cells in SARS‐CoV-2‐exposed organoids display pT231Tau localization at the cell soma specified by AT‐180 (ii), which are not observed in mock organoids (iii). Arrowheads point SARS‐CoV-2‐positive cells (AB4, green) that are also positive for TUNNEL (red), caspase 3 (yellow), and Tau AT‐180 (magenta). Figures display scale bars. Bar diagrams at right quantifies proportions of TUNEL and caspase‐positive cells among SARS‐CoV-2‐positive cells. The second graph below quantifies the proportions of pT231Tau‐positive cells among caspase‐positive cells between control and virus exposed groups. At least 400 cells from four organoids and two independent (n = 2) batches were examined. Unpaired t‐test, **P < 0.01. Data presented as mean ± SEM. TUNEL‐positive cells in control un‐exposed organoids do not contain pT231Tau (iii). Figures display scale bars. Bar diagrams at right quantifies proportions of pT231Tau‐positive cells among TUNNEL‐positive cells between control and virus exposed groups. At least 350 cells from 4 organoids and two independent (n = 2) batches were examined. Unpaired t‐test, ***P < 0.001. Data presented as mean ± SEM.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 63 references

Research works printed but not linked: 1

  1. Flint SJ, Racaniello VR, Rall GF, Skalka AM, Enquist LW (2015) Principles of virology. Washington, DC: ASM Press

Cited by

Items 301–400 of 524

Metadata

Authors
Ramani, A., Müller, L., Ostermann, P. N., Gabriel, E., Abida‐Islam, P., Müller‐Schiffmann, A., Mariappan, A., Goureau, O., Gruell, H., Walker, A., Andrée, M., Hauka, S., Houwaart, T., Dilthey, A., Wohlgemuth, K., Omran, H., Klein, F., Wieczorek, D., Adams, O., Timm, J., Korth, C., Schaal, H., & Gopalakrishnan, J.
Affiliations
  • Düsseldorf University Hospital (DE)
  • Centre National de la Recherche Scientifique (FR)
  • University of Cologne (DE)
  • University Hospital Münster (DE)
Corresponding author
  • Schaal, Heiner
  • Gopalakrishnan, Jay
Venue
The EMBO Journal
Published
2020-09-23
Volume
39
Issue
20
Pages
e106230-e106230
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W3081536095
Cited by
518
References
63
Citations by year
2026: 16 · 2025: 39 · 2024: 71 · 2023: 85 · 2022: 126 · 2021: 145 · 2020: 36
FWCI
42.41
Type
journal article
Language
en
Open access
Licence
Locations
  • The EMBO Journal (publishedVersion, other-oa)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
  • HAL (submittedVersion, other-oa)
Funders
  • Fritz Thyssen Stiftung (10.17.2.018MN)
  • Juergen Manchot Foundation
Topics
  • Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
SARS-CoV-2, COVID-19 pandemic, brain organoids, neuronal infection, neurotoxicity, tau hyperphosphorylation, neuronal cell death, central nervous system pathology
MeSH terms
Betacoronavirus, SARS-CoV-2, Animals, Brain, Chlorocebus aethiops, Humans, Nervous System Diseases, Neurons, Organoids, Vero Cells, tau Proteins, Cell Death

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.